Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology lead asset, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases.


TSX:SVA - Post by User

Comment by MustangSalleyon May 17, 2021 12:37pm
95 Views
Post# 33214483

RE:RE:RE:News . . .

RE:RE:RE:News . . .
MoneyMouth wrote:
  1. By saying that this group of investors are "sophisticated" does not imply that you are not sophisticated. Current shareholders do not need to figure out how "sophisticated" they are. Are you giving us the first lesson in Twisting Words 101
  2. Also, Are you offended by the "understand the value of innovative technologies" line? Is it not obvious what he's trying to say here? I guess not. He's trying to say that these investors are not going to be a bunch of Cannacord like snakes who invest and then short the hell out of the stock to ride free shares. This sounds to me like the real world "Shark Tank" These are the type of investors who are willing to help the company grow, not the type looking to flip some shares for a quick buck. Dr. Toleikis is not slighting any existing shareholders with this quote. 
  3. As mentioned previously, we have until 2030 before patent's run out. You've got to be joking if you think this thing can't be commercialized in the next 9 years. 

It truly baffles me to see how clouded your judgement is that you would take a completely benign quote and try and twist it into some underhanded insult to existing shareholders. It's impressive honestly, but not in a good way.



MoneyMouth,

Toleikis is a one man show . You get a substantial news release once a year . There is no follow up or momentum . You will not get a string of meaningful news releases to move share price . The one and only time you did, Toleikis killed all momentum by doing an awful bought deal that was suppose to bring in new US institutional investors and an analyst report .  So if these European investors are sophisticated , they will already seen the past fluff presentations which Toleikis will regurgitate at nauseaum .  See after May 19 to see how effective this presentation was.


"He's trying to say that these investors are not going to be a bunch of Cannacord like snakes who invest and then short the hell out of the stock to ride free shares. This sounds to me like the real world "Shark Tank" These are the type of investors who are willing to help the company grow, not the type looking to flip some shares for a quick buck."  This is your statement Moneymouth . The fact that Toleikis and Bod allowed this to happen in the first place shows you the level of incompetence and change is needed . We cannot wait until next year .  


Ms Sally 

<< Previous
Bullboard Posts
Next >>